Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CERT Certara	$13.00 +0.5%	$11.23	$8.64 ▼ $15.69	$2.08B	1.45	2.08 million shs	1.50 million shs
SDGR Schrodinger	$20.72 +2.8%	$19.57	$16.60 ▼ $28.47	$1.48B	1.74	1.11 million shs	1.14 million shs
SLP Simulations Plus	$16.47 -0.2%	$14.52	$12.39 ▼ $37.67	$332.10M	0.99	692,078 shs	481,685 shs

7 Stocks to Ride The A.I. Megaboom

We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CERT Certara	+0.54%	-2.77%	+21.50%	+13.04%	+15.66%
SDGR Schrodinger	+2.78%	-2.31%	+6.58%	-4.56%	+20.99%
SLP Simulations Plus	-0.18%	+6.40%	+16.31%	-6.26%	-45.45%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CERT Certara	$13.00 +0.5%	$11.23	$8.64 ▼ $15.69	$2.08B	1.45	2.08 million shs	1.50 million shs
SDGR Schrodinger	$20.72 +2.8%	$19.57	$16.60 ▼ $28.47	$1.48B	1.74	1.11 million shs	1.14 million shs
SLP Simulations Plus	$16.47 -0.2%	$14.52	$12.39 ▼ $37.67	$332.10M	0.99	692,078 shs	481,685 shs

7 Stocks to Ride The A.I. Megaboom

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CERT Certara	+0.54%	-2.77%	+21.50%	+13.04%	+15.66%
SDGR Schrodinger	+2.78%	-2.31%	+6.58%	-4.56%	+20.99%
SLP Simulations Plus	-0.18%	+6.40%	+16.31%	-6.26%	-45.45%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CERT Certara	2.42	Hold	$15.63	20.19% Upside
SDGR Schrodinger	2.38	Hold	$26.29	26.86% Upside
SLP Simulations Plus	2.30	Hold	$24.40	48.15% Upside

Current Analyst Ratings Breakdown

Latest SLP, SDGR, and CERT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/8/2025	CERT Certara	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$15.00 ➝ $16.00
10/8/2025	CERT Certara	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
10/8/2025	SDGR Schrodinger	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$30.00 ➝ $28.00
10/8/2025	SLP Simulations Plus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
10/2/2025	CERT Certara	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$14.00 ➝ $16.00
9/30/2025	SLP Simulations Plus	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Hold
9/30/2025	SLP Simulations Plus	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Hold	$16.00
9/29/2025	SDGR Schrodinger	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$19.00
9/29/2025	CERT Certara	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$16.00
9/29/2025	CERT Certara	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$16.00
9/29/2025	SDGR Schrodinger	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold

(Data available from 10/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CERT Certara	$385.15M	5.42	$0.72 per share	17.97	$6.58 per share	1.98
SDGR Schrodinger	$207.54M	7.35	N/A	N/A	$5.78 per share	3.58
SLP Simulations Plus	$80.38M	4.12	$0.77 per share	21.51	$9.12 per share	1.81

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CERT Certara	-$12.05M	$0.05	260.05	36.11	N/A	1.97%	5.11%	3.50%	11/5/2025 (Estimated)
SDGR Schrodinger	-$187.12M	-$2.48	N/A	N/A	N/A	-76.22%	-45.70%	-24.81%	11/11/2025 (Estimated)
SLP Simulations Plus	$9.95M	-$3.15	N/A	13.07	N/A	-78.63%	11.62%	10.84%	10/22/2025 (Estimated)

Latest SLP, SDGR, and CERT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2025	Q3 2025	CERT Certara	$0.15	N/A	N/A	N/A	$104.53 million	N/A
10/22/2025	Q4 2025	SLP Simulations Plus	$0.07	N/A	N/A	N/A	$16.47 million	N/A
8/6/2025	Q2 2025	CERT Certara	$0.10	$0.07	-$0.03	-$0.01	$104.14 million	$104.57 million
8/6/2025	Q2 2025	SDGR Schrodinger	-$0.83	-$0.59	+$0.24	-$0.59	$52.03 million	$54.76 million
7/14/2025	Q3 2025	SLP Simulations Plus	$0.26	$0.45	+$0.19	-$3.35	$22.83 million	$20.36 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CERT Certara	N/A	N/A	N/A	N/A	N/A
SDGR Schrodinger	N/A	N/A	N/A	N/A	N/A
SLP Simulations Plus	$0.24	1.46%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CERT Certara	0.27	2.16	2.16
SDGR Schrodinger	N/A	3.30	3.30
SLP Simulations Plus	N/A	5.11	5.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CERT Certara	73.96%
SDGR Schrodinger	79.05%
SLP Simulations Plus	78.08%

Insider Ownership

Company	Insider Ownership
CERT Certara	2.33%
SDGR Schrodinger	21.00%
SLP Simulations Plus	19.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CERT Certara	1,546	160.62 million	156.88 million	Optionable
SDGR Schrodinger	790	73.61 million	58.15 million	Optionable
SLP Simulations Plus	160	20.13 million	16.22 million	Optionable

SLP, SDGR, and CERT Headlines

Recent News About These Companies

Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Hold" from Analysts

2 hours ago | marketbeat.com

SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses

October 8 at 7:36 AM | globenewswire.com

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 6 at 8:21 PM | globenewswire.com

SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law

October 6 at 8:36 AM | globenewswire.com

Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

October 6 at 2:24 AM | prnewswire.com

ROSEN, A TOP RANKED LAW FIRM, Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

October 4, 2025 | markets.businessinsider.com

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 3, 2025 | globenewswire.com

SIMULATIONS PLUS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of Investigation into Simulations Plus, Inc. and Encourages Investors to Contact the Firm

October 3, 2025 | globenewswire.com

Simulations Plus (NASDAQ:SLP) Coverage Initiated at TD Cowen

October 2, 2025 | americanbankingnews.com

Deep Dive Into Simulations Plus Stock: Analyst Perspectives (4 Ratings)

October 1, 2025 | benzinga.com

Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues

October 1, 2025 | globenewswire.com

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

September 30, 2025 | globenewswire.com

Simulations Plus (NASDAQ:SLP) Now Covered by TD Cowen

September 30, 2025 | marketbeat.com

Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

September 29, 2025 | prnewswire.com

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

September 27, 2025 | markets.businessinsider.com

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are ...

September 26, 2025 | caledonianrecord.comC

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

September 26, 2025 | globenewswire.com

SLP SHAREHOLDER ALERT: Simulations Plus, Inc. Investors may have been Affected by Fraud -- Contact BFA Law about its Investigation

September 26, 2025 | globenewswire.com

SIMULATIONS PLUS (SLP) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Simulations Plus, Inc. on Behalf of Simulations Plus Stockholders and Encourages Investors to Contact the Firm

September 25, 2025 | globenewswire.com

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman

September 25, 2025 | globenewswire.com

Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

September 24, 2025 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLP, SDGR, and CERT Company Descriptions

Certara NASDAQ:CERT

$13.00 +0.07 (+0.54%)

Closing price 10/8/2025 04:00 PM Eastern

Extended Trading

$13.06 +0.06 (+0.45%)

As of 10/8/2025 07:39 PM Eastern

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Schrodinger NASDAQ:SDGR

$20.72 +0.56 (+2.78%)

Closing price 10/8/2025 04:00 PM Eastern

Extended Trading

$20.70 -0.02 (-0.12%)

As of 10/8/2025 07:57 PM Eastern

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Simulations Plus NASDAQ:SLP

$16.47 -0.03 (-0.18%)

Closing price 10/8/2025 04:00 PM Eastern

Extended Trading

$15.75 -0.72 (-4.37%)

As of 10/8/2025 07:45 PM Eastern

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SLP, SDGR, and CERT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SLP, SDGR, and CERT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SLP, SDGR, and CERT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLP, SDGR, and CERT Company Descriptions

Certara NASDAQ:CERT

Schrodinger NASDAQ:SDGR

Simulations Plus NASDAQ:SLP

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SLP, SDGR, and CERT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SLP, SDGR, and CERT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SLP, SDGR, and CERT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLP, SDGR, and CERT Company Descriptions

Certara NASDAQ:CERT

Schrodinger NASDAQ:SDGR

Simulations Plus NASDAQ:SLP

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools